Thailand's Approach to Drug Quality Assurance: Creation of the Green Book

Posted 27 April 2017 By Thanita Patthamajinda, RPh

placeholder+image This article discusses how Thailand's Ministry of Public Health (MOPH), Food and Drug Administration (Thai FDA) and a number of government and independent health agencies regulate drugs, both new and generic, as well as traditional, nonwestern medicines.

Share this article:

Categories: Drugs, Quality, Features, Asia

Tags: Thailand, Green Book, Quality Assurance

Regulatory Exchange: Latest Updates From the Community